Atlas Trials

Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca

Clinical trial NCT02036359 · UNKNOWN

Trial details

NCT number
NCT02036359
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer(NSCLC)
Start date
2012-05-01
Primary completion
2015-06-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.